InvestorsHub Logo
Followers 20
Posts 1034
Boards Moderated 0
Alias Born 04/08/2014

Re: None

Wednesday, 11/19/2014 2:36:19 PM

Wednesday, November 19, 2014 2:36:19 PM

Post# of 140471
A few of you on here have stated concerns about Titan losing out market share to TRXC (if there still around) and ISRG with the new delay. If you believe robotic surgery to be the future of medicine/healthcare (as I do), then why is this a big concern? If the above turns out to be true then were looking at robotics taking hold even more over the next 5, 10, 20, 30 plus years. Over the grand scheme of things, why does entering a year or so later then these competitors matter? It's not as if there is only a finite amount of customers out there and there won't be any left when Titan finally enters. I guarantee with all of the connections, SAB members, hospitals partners, networking, etc we already have standing orders for when the product is available. The biggest hurdle is actually bringing the product to commercialization. If you have a great product with next generation technology, the customers will come.

There will also be companies entering this market 5 or 10 years from now that are going to be just fine. If they have a viable product, again there will customers for them.

I'm not thrilled about the delay, but I will be shocked if were not out there in 2016. 2017 is either extreme wiggle room, or a timeline to F with ISRG (or any other competitors).

Lastly, Hargove purchasing stock IS a big deal. He's not mega wealthy and this wasn't a symbolic gesture. Had he purchased 100 shares I would have mailed him a paper bag of turds.

GLTA and thanks again Point...